Pyott David E I - Net Worth and Insider Trading
Pyott David E I Net Worth
The estimated net worth of Pyott David E I is at least $110 Million dollars as of 2024-09-20. Pyott David E I is the Chairman of the Board and CEO of Allergan PLC and owns about 399,168 shares of Allergan PLC (AGN) stock worth over $77 Million. Pyott David E I is the Director of Edwards Lifesciences Corp and owns about 290,574 shares of Edwards Lifesciences Corp (EW) stock worth over $20 Million. Pyott David E I is also the Director of Alnylam Pharmaceuticals Inc and owns about 28,036 shares of Alnylam Pharmaceuticals Inc (ALNY) stock worth over $8 Million. Besides these, Pyott David E I also holds Avery Dennison Corp (AVY) , Biomarin Pharmaceutical Inc (BMRN) . Details can be seen in Pyott David E I's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Pyott David E I has not made any transactions after 2024-06-24 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Pyott David E I
Pyott David E I Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Pyott David E I owns 5 companies in total, including Biomarin Pharmaceutical Inc (BMRN) , Alnylam Pharmaceuticals Inc (ALNY) , and Avery Dennison Corp (AVY) among others .
Click here to see the complete history of Pyott David E I’s form 4 insider trades.
Insider Ownership Summary of Pyott David E I
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| BMRN | Biomarin Pharmaceutical Inc | 2020-08-31 | director |
| ALNY | Alnylam Pharmaceuticals Inc | 2024-06-24 | director |
| AVY | Avery Dennison Corp | 2020-02-03 | director |
 | | 2013-05-01 | director |
| | 2021-01-12 | director |
Pyott David E I Latest Holdings Summary
Pyott David E I currently owns a total of 5 stocks. Among these stocks, Pyott David E I owns 399,168 shares of Allergan PLC (AGN) as of February 12, 2014, with a value of $77 Million and a weighting of 69.88%. Pyott David E I owns 290,574 shares of Edwards Lifesciences Corp (EW) as of May 1, 2013, with a value of $20 Million and a weighting of 17.73%. Pyott David E I also owns 28,036 shares of Alnylam Pharmaceuticals Inc (ALNY) as of June 24, 2024, with a value of $8 Million and a weighting of 7.03%. The other 2 stocks Avery Dennison Corp (AVY) , Biomarin Pharmaceutical Inc (BMRN) have a combined weighting of 5.37% among all his current holdings.
Latest Holdings of Pyott David E I
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| AGN | Allergan PLC | 2014-02-12 | 399,168 | 193.02 | 77,047,407 |
| EW | Edwards Lifesciences Corp | 2013-05-01 | 290,574 | 67.26 | 19,544,007 |
| ALNY | Alnylam Pharmaceuticals Inc | 2024-06-24 | 28,036 | 276.33 | 7,747,188 |
| AVY | Avery Dennison Corp | 2020-02-03 | 17,270 | 215.77 | 3,726,348 |
| BMRN | Biomarin Pharmaceutical Inc | 2020-08-31 | 30,740 | 71.43 | 2,195,758 |
Holding Weightings of Pyott David E I
Pyott David E I Form 4 Trading Tracker
According to the SEC Form 4 filings, Pyott David E I has made a total of 0 transactions in Allergan PLC (AGN) over the past 5 years. The most-recent trade in Allergan PLC is the sale of 252,000 shares on February 12, 2014, which brought Pyott David E I around $31 Million.
According to the SEC Form 4 filings, Pyott David E I has made a total of 0 transactions in Edwards Lifesciences Corp (EW) over the past 5 years. The most-recent trade in Edwards Lifesciences Corp is the acquisition of 18,000 shares on May 1, 2013, which cost Pyott David E I around $188,850.
According to the SEC Form 4 filings, Pyott David E I has made a total of 1 transactions in Alnylam Pharmaceuticals Inc (ALNY) over the past 5 years, including 0 buys and 1 sells. The most-recent trade in Alnylam Pharmaceuticals Inc is the sale of 32,450 shares on June 24, 2024, which brought Pyott David E I around $7 Million.
More details on Pyott David E I's insider transactions can be found in the Insider Trading History of Pyott David E I table.Insider Trading History of Pyott David E I
- 1
Pyott David E I Trading Performance
GuruFocus tracks the stock performance after each of Pyott David E I's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Pyott David E I is 12.48%. GuruFocus also compares Pyott David E I's trading performance to market benchmark return within the same time period. The performance of stocks bought by Pyott David E I within 3 months outperforms 3 times out of 4 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Pyott David E I's insider trading performs compared to the benchmark.
Performance of Pyott David E I
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 7.06 | | | | | |
| Relative Return to S&P 500(%) | 7.57 | | | | | |
Pyott David E I Ownership Network
Pyott David E I Owned Company Details
What does Biomarin Pharmaceutical Inc do?
Who are the key executives at Biomarin Pharmaceutical Inc?
Pyott David E I is the director of Biomarin Pharmaceutical Inc. Other key executives at Biomarin Pharmaceutical Inc include GVP & Chief Accounting Officer Erin Burkhart , EVP & Chief Financial Officer Brian Mueller , and VP & General Counsel George Eric Davis .
Biomarin Pharmaceutical Inc (BMRN) Insider Trades Summary
Over the past 18 months, Pyott David E I made no insider transaction in Biomarin Pharmaceutical Inc (BMRN). Other recent insider transactions involving Biomarin Pharmaceutical Inc (BMRN) include a net sale of 263,000 shares made by Jean Jacques Bienaime , a net sale of 92,066 shares made by George Eric Davis , and a net sale of 14,000 shares made by Jeffrey Robert Ajer .
In summary, during the past 3 months, insiders sold 714 shares of Biomarin Pharmaceutical Inc (BMRN) in total and bought 0 shares, with a net sale of 714 shares. During the past 18 months, 438,267 shares of Biomarin Pharmaceutical Inc (BMRN) were sold and 0 shares were bought by its insiders, resulting in a net sale of 438,267 shares.
Biomarin Pharmaceutical Inc (BMRN)'s detailed insider trading history can be found in Insider Trading Tracker table.
Biomarin Pharmaceutical Inc Insider Transactions
Pyott David E I Mailing Address
Above is the net worth, insider trading, and ownership report for Pyott David E I. You might contact Pyott David E I via mailing address: C/o Allergan, 2525 Dupont Drive, Irvine Ca 92612.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
